Daewon Pharmaceutical Co., Ltd. (KRX:003220)
13,310
+40 (0.30%)
At close: Aug 14, 2025, 3:30 PM KST
Daewon Pharmaceutical Market Cap
Daewon Pharmaceutical has a market cap or net worth of 285.28 billion as of August 15, 2025. Its market cap has decreased by -27.76% in one year.
Market Cap
285.28B
Enterprise Value
418.76B
Revenue
597.69B
Ranking
n/a
PE Ratio
24.79
Stock Price
13,310.00
Market Cap Chart
Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 285.28B, an increase of 1,479.62%. That is a compound annual growth rate of 11.94%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.52T |
Celltrion | 38.58T |
ALTEOGEN | 23.35T |
Yuhan | 8,561.74B |
Peptron | 8,235.61B |
SK Biopharmaceuticals | 7,878.31B |
PharmaResearch | 7,106.52B |
LigaChem Biosciences | 5,666.20B |